Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Cerebrovascular Disorders × CNS × Clear all

Phase

Phase NA 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 32 Glioblastoma 6 Glioma 5 Epilepsy 5 Neuroblastoma 4 Meningeal Carcinomatosis 4 Neoplasms 3 Neoplasm Metastasis 3 Meningioma 3 Seizures 2 Retinoblastoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pituitary Neoplasms 2 Paraganglioma 2 Neuroma, Acoustic 2 Neurofibromatosis 1 2 Melanoma 2 Medulloblastoma 2 Lung Neoplasms 2 Delirium 2 Central Nervous System Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Stroke 1 Spinal Cord Neoplasms 1 Restless Legs Syndrome 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Parkinson Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02478346 2017-02-14

Fluoescein

AdventHealth

Phase 4 Unknown

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡